OTC Pharmaceuticals - Tunisia

  • Tunisia
  • Revenue in the OTC Pharmaceuticals market amounts to US$216.50m in 2024. The market is expected to grow annually by 4.39% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$70.05m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$17.23 are generated in 2024.
  • In the OTC Pharmaceuticals market, 1.8% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Tunisia is experiencing steady growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of the market.

Customer preferences in Tunisia play a significant role in driving the growth of the OTC Pharmaceuticals market. Consumers in the country are increasingly seeking convenience and accessibility when it comes to healthcare products. OTC medications offer a convenient solution for minor ailments and allow consumers to self-diagnose and self-treat common health issues.

The preference for OTC medications is also driven by the desire to avoid long waiting times at healthcare facilities and the associated costs. Trends in the OTC Pharmaceuticals market in Tunisia reflect global and regional patterns. One notable trend is the increasing demand for natural and herbal remedies.

Consumers are becoming more health-conscious and are actively seeking products that are perceived to be more natural and have fewer side effects. This trend is driving the growth of herbal and natural OTC medications in the market. Another trend in the market is the rising popularity of online pharmacies and e-commerce platforms.

The convenience of ordering medications online and having them delivered to their doorstep is appealing to consumers. Online pharmacies also provide a wider range of products and competitive pricing, further driving their popularity in the market. Local special circumstances in Tunisia also contribute to the development of the OTC Pharmaceuticals market.

The country has a well-established healthcare system and a growing middle class with increasing disposable income. This combination creates a favorable environment for the growth of the OTC Pharmaceuticals market. Additionally, the government has implemented healthcare reforms to improve access to healthcare services, which has further boosted the demand for OTC medications.

Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in Tunisia. The country has experienced stable economic growth in recent years, which has increased the purchasing power of consumers. This, in turn, has led to increased spending on healthcare products, including OTC medications.

Furthermore, the government's focus on healthcare and investment in the pharmaceutical sector has created a conducive environment for the growth of the market. Overall, the OTC Pharmaceuticals market in Tunisia is developing and expanding due to customer preferences for convenience, accessibility, and natural remedies, as well as trends in the market such as the rise of online pharmacies. Local special circumstances, including a well-established healthcare system and government reforms, and underlying macroeconomic factors like stable economic growth, further contribute to the positive trajectory of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)